Related Experiment Videos

Leukoencephalopathy following high-dose intravenous methotrexate chemotherapy: quantitative assessment of white

Neuroradiology
|January 1, 1978
PubMed

Insights

Leukoencephalopathy can occur in children treated for acute lymphatic leukemia or bone tumors with certain chemotherapy regimens. A new computerized CT scan analysis method offers a more reliable way to detect white matter changes than visual assessment.

Area of Science:

  • Neuro-oncology
  • Pediatric oncology
  • Radiology

Background:

  • Leukoencephalopathy is a known complication in children treated for acute lymphatic leukemia (ALL) using cranial radiation therapy and methotrexate.
  • High-dose methotrexate (MTX) with citrovorum factor (CF) for bone tumors can also induce leukoencephalopathy, even without cranial irradiation.

Observation:

  • Computed tomography (CT) scans may show decreased white matter attenuation in affected patients.
  • Visual assessment of white matter hypodensity on CT scans can be unreliable.

Findings:

  • A computerized method was developed to analyze white matter hypodensity by calculating the mean attenuation coefficient from CT slices.
  • Serial comparisons of this mean attenuation coefficient provide a more reliable assessment of leukoencephalopathy than visual appraisal.

Implications:

  • This quantitative CT analysis method can improve the detection and monitoring of methotrexate-induced leukoencephalopathy in pediatric cancer patients.
  • Accurate identification of leukoencephalopathy is crucial for treatment adjustments and managing long-term neurological sequelae.

Related Concept Videos